Howe & Rusling’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-67
Closed -$1K 507
2022
Q3
$1K Buy
67
+12
+22% +$264 ﹤0.01% 950
2022
Q2
$1K Sell
55
-43
-44% -$920 ﹤0.01% 938
2022
Q1
$2K Buy
98
+25
+34% +$564 ﹤0.01% 846
2021
Q4
$2K Buy
+73
New +$2.55K ﹤0.01% 849

Other funds holding DH

Howe & Rusling's DH Position: Q4 2022 in Review

Howe & Rusling sold out of Definitive Healthcare (DH) in Q4 2022, closing a stake of 67 shares — an estimated $1K sold.

Howe & Rusling first reported a position in DH in Q4 2021 and held it in 4 quarters. The position peaked at $2K in Q1 2022. 136 funds tracked by Wall St. Rank hold DH as of Q4 2022.

  • Howe & Rusling reported no remaining Definitive Healthcare position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 67 Definitive Healthcare shares in Q4 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Definitive Healthcare in Q4 2021 and held it in 4 quarters.
  • Howe & Rusling's Definitive Healthcare position peaked at $2K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.